Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

SELL
$41.39 - $81.0 $48.1 Million - $94.1 Million
-1,162,090 Reduced 96.91%
37,062 $1.67 Million
Q3 2022

Nov 14, 2022

BUY
$72.36 - $113.1 $219,178 - $342,579
3,029 Added 0.25%
1,199,152 $86.8 Million
Q2 2022

Aug 11, 2022

SELL
$87.2 - $114.05 $799,536 - $1.05 Million
-9,169 Reduced 0.76%
1,196,123 $128 Million
Q1 2022

May 13, 2022

SELL
$94.19 - $124.49 $355,002 - $469,202
-3,769 Reduced 0.31%
1,205,292 $134 Million
Q4 2021

Feb 11, 2022

BUY
$119.57 - $139.07 $16.9 Million - $19.7 Million
141,490 Added 13.25%
1,209,061 $155 Million
Q3 2021

Nov 12, 2021

BUY
$109.17 - $142.35 $312,881 - $407,975
2,866 Added 0.27%
1,067,571 $142 Million
Q2 2021

Aug 13, 2021

SELL
$100.34 - $115.69 $82,880 - $95,559
-826 Reduced 0.08%
1,064,705 $115 Million
Q1 2021

May 13, 2021

SELL
$101.51 - $125.27 $93,287 - $115,123
-919 Reduced 0.09%
1,065,531 $112 Million
Q4 2020

Feb 10, 2021

SELL
$85.88 - $105.36 $8.4 Million - $10.3 Million
-97,828 Reduced 8.4%
1,066,450 $111 Million
Q3 2020

Nov 12, 2020

SELL
$72.74 - $92.5 $346,751 - $440,947
-4,767 Reduced 0.41%
1,164,278 $99.7 Million
Q2 2020

Aug 14, 2020

SELL
$48.02 - $79.04 $8.89 Million - $14.6 Million
-185,138 Reduced 13.67%
1,169,045 $85.7 Million
Q1 2020

May 15, 2020

BUY
$36.95 - $62.95 $20.1 Million - $34.3 Million
544,186 Added 67.18%
1,354,183 $70.4 Million
Q4 2019

Feb 14, 2020

BUY
$47.06 - $56.64 $8.06 Million - $9.7 Million
171,243 Added 26.81%
809,997 $45.8 Million
Q3 2019

Nov 14, 2019

BUY
$47.45 - $58.05 $30.3 Million - $37.1 Million
638,754 New
638,754 $30.4 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Clearbridge Investments, LLC Portfolio

Follow Clearbridge Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.